// App-Quantinova.ai

OA07 : Clinical and pathogenic significance of S100A4 overexpression in systemic sclerosis

Researchers

Presenter

  • Christopher P Denton

Principal Investigators

  • Shiwen Xu

  • Rory H Maclean

  • Kristina E Clark

  • Signe Borchert

  • Rizwan Hussain

  • Jorg Klingelhöfer

  • Jonas Hallen

  • Voon H Ong

Medical Centers

  • ARXX Therapeutics, Symbion Science Park, Copenhagen, Denmark

  • Division of Medicine, University College London, London, United Kingdom

Locations

  • Denmark

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

  • Genetic Disorder

  • Central Nervous System (CNS)

Disease

  • Scleroderma

  • Mental retardation, X-linked, syndromic, 15

Biomarkers

  • N/A

Drug/Treatment

  • AX-202

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final